Similar articles

• A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.

  Peto TE. Peto TE. AIDS. 1990;4 Suppl 1:S187-91. AIDS. 1990. PMID: 2152565 Review. No abstract available.
• [The treatment of 12 HIV-infected children with zidovudine].

  Scherpbier HJ, Prakken AB, de Graeff-Meeder ER, van den Berg H. Scherpbier HJ, et al. Ned Tijdschr Geneeskd. 1993 Aug 7;137(32):1610-3. Ned Tijdschr Geneeskd. 1993. PMID: 8366963 Dutch.
• [Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].

  Stamminger T, Fleckenstein B. Stamminger T, et al. Fortschr Med. 1994 May 10;112(13):190-1. Fortschr Med. 1994. PMID: 8020860 German. No abstract available.
• [Therapy of HIV infection with zidovudine (AZT)].

  Goebel FD. Goebel FD. Verh Dtsch Ges Inn Med. 1990;96:530-3. Verh Dtsch Ges Inn Med. 1990. PMID: 2092478 Review. German. No abstract available.
• [Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].

  [No authors listed] [No authors listed] Ugeskr Laeger. 1993 Jan 11;155(2):104-7. Ugeskr Laeger. 1993. PMID: 8421854 Clinical Trial. Danish. No abstract available.